Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Breast Cancer Research Program Era of Hope Scholar Award

Congressionally Directed Medical Research Programs

Supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the intent of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the Principal Investigator (PI) to go beyond conventional thinking in their field and the innovative contributions that they can make toward ending breast cancer. PIs should be exceptionally talented scientists that are among “the best and the brightest” in their field(s), have demonstrated experience forming effective partnerships and collaborations, and exhibit strong potential for future leadership in breast cancer research. Applications must address one of the FY25 BCRP overarching challenges, unless adequate justification for exception is provided.

Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot approximately $10.85 million (M) to fund two Era of Hope Scholar Award applications with direct cost caps of $3.50M. The maximum period of performance is four years. It is anticipated that the award made from this FY25 funding opportunity will be funded with FY25 funds, which will expire for use on September 30, 2031. An award supported with FY25 funds will be made no later than September 30, 2026.

Specialties

Cancer

Oncology

Clinical Trials

Eligibility Requirements

Organization

Extramural and intramural organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.

Extramural Organization: An eligible non-Department of Defense (DOD) organization. Examples of extramural organizations include academic institutions, biotechnology companies, foundations, federal government organizations other than the DOD (i.e., intragovernmental organizations), and research institutes.

Intramural DOD Organization: Refers specifically to DOD organizations, including DOD laboratories, DOD military treatment facilities, and/or DOD activities embedded within a civilian medical center.

Principal Investigator

The PI must be an independent and non-mentored investigator within six years of their last training position as of the application submission deadline (excluding time spent on family medical leave). The PI may articulate lapses in research time or appointments denoted in the biographical sketch within the application. Examples of training positions include postdoctoral fellowship, medical residency, and clinical fellowship. Postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are not eligible.

The PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award.

Individuals affiliated with an eligible organization are eligible to be named as PI regardless of ethnicity, nationality, or citizenship status.

Sponsor Details

Sponsor Institute/Organizations: Congressionally Directed Medical Research Programs

Sponsor Type: Corporate/Non-Profit

Address: Fort Detrick Frederick, MD 21702

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity